PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Gesamtlänge aller Episoden: 1 day 13 hours 59 minutes
Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
Perspectives in Acute Hepatic Porphyria Care: Improving Long-Term Management with Novel Therapeutics
Treatment Goals in Systemic Lupus Erythematosus: How Are We Raising the Bar?
Treatment Goals in Systemic Lupus Erythematosus: How Are We Raising the Bar?
Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
Suspecting and Diagnosing Inherited Retinal Dystrophies: Early Clues and Confirmatory Testing
Evolving Therapies in Multiple Sclerosis: BTK Inhibitors
Evolving Therapies in Multiple Sclerosis: BTK Inhibitors
Acute Psychosis: When to Suspect Acute Hepatic Porphyria
Acute Psychosis: When to Suspect Acute Hepatic Porphyria
Suspecting, Diagnosing and Managing Multifocal Motor Neuropathy: A Patient Investigation
Suspecting, Diagnosing and Managing Multifocal Motor Neuropathy: A Patient Investigation
If I'd Known Then What I Know Now: Recognising My First AHP Patient
If I'd Known Then What I Know Now: Recognising My First AHP Patient
Acute Polyneuropathy With Abdominal Pain: Could It be Acute Hepatic Porphyria?
Acute Polyneuropathy With Abdominal Pain: Could It be Acute Hepatic Porphyria?
"Menstruation Triggering Severe Unexplained Abdominal Pain: Could It Be Acute Hepatic Porphyria?"
"Menstruation Triggering Severe Unexplained Abdominal Pain: Could It Be Acute Hepatic Porphyria?"
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know
Stroke Prevention, Type 2 Diabetes, and GLP-1 Receptor Agonists: What Neurologists Need to Know